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Objectives: Sociocultural factors have been hypothesized as important drivers of inappropriate antibiotic pre-
scribing in European ambulatory care. This study sought to assess whether they can also explain the reported
variation in broad-spectrum antibiotic (Br-Ab) use among EU/European Economic Area (EEA) countries.
Methods: Correlation and regression analysis were performed, using the bootstrap method, between Br-Ab
ratios reported from 28 EU countries by the ECDC, and national Hofstede cultural dimensions and control of cor-
ruption (CoC) scores.
Results: Significant bootstrapping correlation coefficients were identified between Br-Ab ratios and the dimen-
sion of uncertainty avoidance (UAI) as well as CoC. However, following both bootstrapping multiple regression
and generalized linear modelling, only UAI was retained as the sole predictor. A logarithmic model explained
58.6% of the variation in European Br-Ab variability solely using national UAI scores (P,0.001).
Conclusions: Br-Ab prescribing appears to be driven by the level of UAI within the country. Any interventions
aimed at reducing Br-Ab in high-consuming EU/EEA countries need to address this cultural perception to maxi-
mize their chances of success.
Introduction
The importance of social and behavioural factors in antibiotic pre-
scribing has been belatedly recognized.1 Cultural determinants
have arguably provided the most plausible explanation for the
variation in antibiotic consumption levels between countries of the
EU and European Economic Area (EEA),2 as well as in practices that
are either anathema to basic medical principles (prescribing of
antibiotics for colds, influenza and sore throat),3 or which are in-
compatible with irrefutable scientific evidence (excessively pro-
longed surgical prophylaxis).4 These studies have utilized the
anthropological model developed by Geert Hofstede, which pro-
poses that national cultures vary along consistent, fundamental
dimensions (Table 1).5 The behavioural constructs of power dis-
tance (PDI), masculinity (MAS) and uncertainty avoidance (UAI)
appear to be particularly relevant.6 More recently, an association
between antibiotic use in Europe and levels of corruption has also
been suggested.7
It has long been reported that a significant variability exists in
broad-spectrum antibiotic (Br-Ab) use between EU/EEA countries.8
Narrow-spectrum formulations, especially penicillin V, are pre-
dominantly used in Scandinavia for the treatment of respiratory
infections whereas doctors in southern and eastern European
countries generally prescribe antimicrobials with a far wider spec-
trum of activity for the same conditions. This variability is import-
ant because Br-Abs are known to be potent disrupters of the
human microbiome, especially within the large intestine, which
can result in the proliferation of resistant mutants.9 No plausible
explanation has been provided for this geographical disparity.
Indeed, Br-Ab prescribing decisions in high-consuming countries
are often at odds with local antimicrobial resistance (AMR) epi-
demiology.10 We therefore sought to investigate whether
Hofstede’s cultural dimensions can also explain the differences in
Br-Ab use within EU/EEA countries.
Methods
For the purpose of the study, information on Br-Ab use in community care
within the EU/EEA was sourced from the publicly available antimicrobial
consumption database of ESAC-Net, a surveillance network coordinated by
the ECDC (https://ecdc.europa.eu/en/antimicrobial-consumption/surveil
lance-and-disease-data/database). One of the quality indicators reported
by this database is the broad-spectrum index (BrSI). It calculates the aver-
age ratio of consumption of broad-spectrum penicillins, cephalosporins
and macrolides (except erythromycin) against consumption of narrow-
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spectrum penicillins, cephalosporins and macrolides (erythromycin) per
country. BrSI ratios for the years 2015, 2016 and 2017 were extracted from
the ECDC database. Countries unable to provide separate community data
(Cyprus, Romania) were excluded from the analysis. In order to reduce pos-
sible inter-year reporting variability, the BrSI for each country was averaged
for the three study years. Scores for PDI, MAS, UAI, individualism (IDV),
long-term orientation (LTO) and indulgence (IVR) were collated from
Hofstede’s publicly available resource (https://www.hofstede-insights.com/
product/compare-countries). Control of corruption (CoC) indices were
extracted from the World Bank Worldwide Governance Indicators (https://
datacatalog.worldbank.org/dataset/worldwide-governance-indicators).
The respective data per country were input into Excel (Microsoft Excel
2016, Microsoft Corp.) for preliminary evaluation and averaging of BrSI
ratios. The bootstrapping method was used to obtain robust individual esti-
mates of correlation and regression coefficients within the BrSI dataset.
This method was chosen because of the small sample size (28 countries)
and violation of certain assumptions, including normality and homoscedas-
ticity. Correlation coefficients were computed to separately assess the
strength of the relationship between the BrSI ratios and each of the six
Hofstede cultural dimensions and CoC scores. Multiple bootstrapped re-
gression analysis as well as generalized linear modelling were then used to
analyse all the predictors collectively, in order to take into account their mu-
tual effect. Analyses were performed using Statistical Package for the Social
Sciences, Version 25 (SPSS Inc., Chicago, IL, USA) assuming a 0.05 level of
significance.
Results
The average BrSI country ratio for the years 2015 to 2017 ranged
from 0.18 in Norway to 245 in Greece and Italy (Figure 1). The boot-
strapping 95% CI of the correlation coefficients between BrSI and
each cultural score as well as with the CoC index showed signifi-
cant, positive correlation with UAI (95% CI"0.337 to 0.771) and
negative correlation with CoC (95% CI"#0.692 to#0.192). At the
same time, UAI was significantly negatively associated with CoC
(95% CI"#0.799 to#0.424). Following bootstrapped multiple re-
gression analysis, only UAI was retained as a significant predictor
in the model fit. Repeating the analysis using a generalized linear
model yielded the same outcome, with UAI again being the sole
predictor (95% CI"#0.0014 to #0.0004). Regression analysis of
UAI, after logarithmic transformation of BrSI to address the skew-
ness and satisfy normality assumptions, yielded a model with
R2"0.586 and P,0.001 (Figure 2).
Discussion
Our study continues to highlight that antibiotic prescribing in EU/
EEA countries appears to be strongly influenced by deep-rooted,
socio-anthropological values. It is not surprising that, of all the cul-
tural dimensions, UAI was the variable that showed a significant
relationship with Br-Ab prescribing. This dimension estimates the
extent to which a society tolerates uncertainty and ambiguity.
High-UAI cultures often try to counteract the unease created by
situations of uncertainty through adoption of dogmatic, bureau-
cratic or excessive measures, even where there is no evidence of
cost-effectiveness or risk attenuation.5 Community-associated
infections present a challenge of ambiguity to the clinician, espe-
cially since laboratory diagnostic support is often unavailable.11 In
high-UAI countries, prescribing Br-Ab can be hypothesized to offer
a means of assuaging that uncertainty. The CoC index was the
only other factor that exhibited significant univariate correlation
with BrSI. Various theories have been put forward to explain the
link between corruption and inappropriate antibiotic use in Europe,
including bribery and financial dependence of doctors on pharma-
ceutical firms.7 The fact that corruption was ultimately found to be
non-significant in our study suggests that the relationship is spuri-
ous, the result of the already-reported strong association between
CoC and UAI.12 We postulate that doctors in high-UAI countries
opt for broader-spectrum formulations, not for nefarious reasons,
but instinctively to lessen uncertainty and obtain a perceived
reassurance that any possible pathogen would be covered ‘just in
case’!6
The log regression model explained almost 60% of the variation
in BrSI between EU/EEA countries solely from the UAI country
score, which is a completely unrelated anthropological measure-
ment. While correlation does not automatically infer causality, cul-
tural determinants have now provided explanations for practically
every aspect of inappropriate antibiotic prescribing in Europe.5
Indeed, these behavioural drivers offer a far more plausible ration-
ale to elucidate the heterogeneity of antibiotic quality indicators in
the EU/EEA than any economic or structural factors.13 Schein14 has
defined culture as ‘a pattern of shared basic assumptions learned
by a group as it solved its problems of external adaptation and in-
ternal integration’. Changing such a deep-rooted ‘software of
the mind’5 is unlikely to be achieved using solely educational
Table 1. Hofstede cultural dimensions, adapted from Hofstede et al.5
Power distance (PDI) Indicates how hierarchy and power distribution are organized within society. In high PDI cultures, less powerful mem-
bers accept and expect that power is distributed unequally.
Uncertainty avoidance (UAI) Indicates the extent to which a society tolerates uncertainty and ambiguity. In high UAI cultures, individuals feel
discomfort and stress in unstructured situations that are novel, unknown or different from usual.
Individualism (IDV) Refers to the integration of individuals within society. In high IDV cultures, people tend to value independence and
form loose groups, in contrast to tight inter-dependent groups of collectivist societies.
Masculinity (MAS) Refers to the distribution of roles within society. In masculine cultures, ego needs, assertiveness, targets and success
are emphasized, whereas feminine cultures focus on caring for the weak and quality of life.
Long-term orientation (LTO) Reflects long-term pragmatic versus short-term normative attitudes. Cultures scoring high on LTO show a pragmatic
emphasis on future rewards and adaptation to changing circumstances.
Indulgence (IVR) Reflects societies that encourage people to enjoy life and have fun as opposed to societies where restraint is
emphasized.
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interventions. Indeed, Schein14 goes further in pointing out that
‘human minds need cognitive stability and any challenge of a basic
assumption will release anxiety and defensiveness’. The majority
of publications describing successful antibiotic stewardship inter-
ventions tend to originate from North America, Australia, the
British Isles and Scandinavia.15 They are invariably underpinned by
a strong adhocratic emphasis on multidisciplinary treatment
guidelines.16 Such an approach is congruent with their low UAI and
PDI; a cultural combination that is found in no other countries
worldwide.5 However, attitudes to antibiotic guidelines are often
very different among doctors within high-UAI and -PDI countries,
who may widely view them as an infringement of their prescribing
power and being less relevant than the perceived certainty of an-
ecdotal personal experiences.17
Since countries with high Br-Ab prescribing also exhibit
above-average AMR, it could be postulated that Br-Ab prescrib-
ing may be driven by a clinical need. Yet the highest con-
sumption of quinolones occurs in countries where resistance
within Gram-negative bacteria exceeds 25%, well beyond
the safe threshold for empirical prescribing.18 The same
applies for broad-spectrum b-lactams and penicillin-resistant
Streptococcus pneumoniae.19 Above all, the hypothesis is not
supported by the findings of AMR country visits carried out by
the ECDC in recent years within high-prescribing EU/EEA coun-
tries.20 A study of this specific focus will invariably have some
limitations. Other factors not included in the model, such as
population, geographic distribution, pharmaceutical availabil-
ities and healthcare structures, could be relevant drivers of Br-
Ab prescribing behaviour. However, studies that looked at the
differences in antibiotic consumption between EU/EEA coun-
tries have failed to identify any such structural determinants.13
Even if some confounding were to be a factor, the high
correlation identified suggests that cultural determinants,
which have been in existence for thousands of years, are likely
major drivers behind the observed variation in the prescribing
of Br-Abs within EU/EEA countries. It is therefore not surprising
that antibiotic practices in many southern and eastern
European countries remain a massive challenge, despite more
than a decade of guideline development and awareness
campaigns.21,22
Our study is relevant because it suggests that interventions
aimed at reducing Br-Ab prescribing in high-consuming EU/EEA
countries cannot remain purely medical in nature but must ad-
dress underlying cultural traits among the prescribers. An obvious
approach would be to reduce the element of uncertainty in the
diagnosis and treatment of community infections for both doctor
and patient. Adoption of rapid antigen detection testing (RADT)
by GPs in Spain, a country with high UAI, successfully reduced in-
appropriate prescribing.23 Even so, antibiotics were still prescribed
in more than 30% of cases with negative RADT results, supporting
the pervasive effect of cultural drivers. Tacconelli and Pezzani24
have proposed that the only way to improve prescribing practices
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Figure 1. Br-Ab ratio for the 28 studied EU/EEA countries (source: ECDC) aggregated for the years 2015 to 2017.
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in high-consuming European countries is through mandated tar-
gets and national consequences for suboptimal practices. If such
initiatives can permeate down to prescriber level, the accountabil-
ity element would introduce a new uncertainty factor in the equa-
tion that could displace the one created by the clinical situation.
Well-designed behaviour change studies from high-UAI countries
are sorely needed to inform more effective antibiotic stewardship
programmes in these settings.
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